Literature DB >> 7871036

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

L A Dunn1, G E Atwater, C D Kilts.   

Abstract

Latent inhibition (LI) of a conditioned emotional response (CER) has been proposed as a quantitative measure of selective attention. We have assessed the parallels of the pharmacology of LI in rats with the clinical pharmacology of schizophrenia. Drug and vehicle treated rats were divided into groups and preexposed 20 times to cage illumination as a CS, or not preexposed. All groups were conditioned with 2 CS-footshock pairings. The following day CER, as measured by interruption of drinking in response to CS presentation, was recorded. LI was observed as a decreased CER in preexposed relative to non-preexposed animals. LI was enhanced by haloperidol 0.3 mg/kg after 7 or 14 daily treatments, but not after a single acute dose. Haloperidol doses of 0.3 and 0.03 mg/kg enhanced LI, while doses of 0.003 and 3.0 mg/kg had no effect. Haloperidol enhancement of LI was unaffected by the coadministration of the anticholinergic agent trihexyphenidyl. Enhancement of LI is exhibited by the antipsychotic drugs fluphenazine, chlorpromazine, thiothixene, thioridazine, mesoridazine, and metoclopramide but not clozapine. The non-antipsychotic drugs pentobarbital, imipramine, chlordiazepoxide, trihexyphenidyl, and promethazine failed to enhance LI. LI exhibits striking parallels to the clinical pharmacology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7871036     DOI: 10.1007/bf02244927

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Interaction of serotonin- and dopaminergic systems of the brain in mechanisms of latent inhibition in rats.

Authors:  L V Loskutova
Journal:  Neurosci Behav Physiol       Date:  1990 Nov-Dec

2.  The effect of anti-psychotic medication and diagnostic criteria on distractibility in schizophrenia.

Authors:  T F Oltmanns; J Ohayon; J M Neale
Journal:  J Psychiatr Res       Date:  1978       Impact factor: 4.791

Review 3.  Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.

Authors:  R J Baldessarini; D Tarsy
Journal:  Annu Rev Neurosci       Date:  1980       Impact factor: 12.449

4.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

Review 5.  Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

Authors:  R J Baldessarini; B M Cohen; M H Teicher
Journal:  Arch Gen Psychiatry       Date:  1988-01

6.  Forebrain monoamines and associative learning: I. Latent inhibition and conditioned inhibition.

Authors:  J F Lorden; E J Rickert; D W Berry
Journal:  Behav Brain Res       Date:  1983-08       Impact factor: 3.332

7.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

8.  Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.

Authors:  J P McEvoy; G E Hogarty; S Steingard
Journal:  Arch Gen Psychiatry       Date:  1991-08

9.  Information processing and neuroleptic response in acute and stabilized schizophrenic patients.

Authors:  S R Marder; R F Asarnow; T Van Putten
Journal:  Psychiatry Res       Date:  1984-09       Impact factor: 3.222

10.  Role of central noradrenaline neurons in the contextual control of latent inhibition in taste aversion learning.

Authors:  A K Mohammed; N E Callenholm; T U Järbe; M D Swedberg; W Danysz; T W Robbins; T Archer
Journal:  Behav Brain Res       Date:  1986-08       Impact factor: 3.332

View more
  22 in total

1.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

2.  Involvement of D1 and D2 dopamine receptor in the retrieval processes in latent inhibition.

Authors:  E Diaz; J Medellín; N Sánchez; J P Vargas; J C López
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

Review 3.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.

Authors:  E B Binder; B Kinkead; M J Owens; C D Kilts; C B Nemeroff
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

5.  Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.

Authors:  Tatiana V Lipina; Oksana Kaidanovich-Beilin; Satish Patel; Min Wang; Steven J Clapcote; Fang Liu; James R Woodgett; John C Roder
Journal:  Synapse       Date:  2011-03       Impact factor: 2.562

6.  Effects of nicotine and amphetamine on latent inhibition in human subjects.

Authors:  J C Thornton; S Dawe; C Lee; C Capstick; P J Corr; P Cotter; S Frangou; N S Gray; M A Russell; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

7.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

8.  A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.

Authors:  Tatiana Lipina; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2009-12-16       Impact factor: 4.530

9.  Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Authors:  Inna Gaisler-Salomon; Gretchen M Miller; Nao Chuhma; Sooyeon Lee; Hong Zhang; Farhad Ghoddoussi; Nicole Lewandowski; Stephen Fairhurst; Yvonne Wang; Agnès Conjard-Duplany; Justine Masson; Peter Balsam; René Hen; Ottavio Arancio; Matthew P Galloway; Holly M Moore; Scott A Small; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

10.  The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain.

Authors:  Xiao-Wei Dong; Yuping Jia; Sherry X Lu; Xiaoping Zhou; Mary Cohen-Williams; Robert Hodgson; Huiqing Li; Tony Priestley
Journal:  Psychopharmacology (Berl)       Date:  2007-09-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.